US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Korro Bio, Inc.

11.76

+0.28002.44%

Volume:181.74K

Turnover:2.13M

Market Cap:110.75M

PE:-1.25

High:11.96

Open:11.43

Low:11.35

Close:11.48

52wk High:55.89

52wk Low:5.20

Shares:9.42M

Float Shares:5.74M

Volume Ratio:0.62

T/O Rate:3.16%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-9.4227

EPS(LYR):-9.3695

ROE:-63.46%

ROA:-29.16%

PB:1.12

PE(LYR):-1.26

Loading ...

Overview Company News Filings

Korro Bio upgraded to Overweight from Neutral at Cantor Fitzgerald

Korro Bio price target raised to $10 from $7 at Clear Street

Korro Bio Inc. Releases Overview of KRRO-121 RNA Editing Therapy for Ammonia Control

Korro Bio Showcases KRRO-121 RNA Editing Program Progress

Korro Bio Hosts Virtual Analyst Day to Spotlight KRRO-121 for Hyperammonemia

Korro Bio Updates Pipeline, Terminates KRRO-110 REWRITE Trial

Korro Bio Unveils Pipeline Advancements in RNA Editing for Genetic Medicines

Korro Bio Boosts Executive Pay and Severance in New Agreement

Korro Bio Early Trial Results Fall Short; Stock Hits New Low

Korro failure strengthens Wave Life Sciences position, says Jefferies

Korro Bio downgraded to Neutral from Overweight at Piper Sandler

Korro Bio Cut to Neutral From Buy by HC Wainwright & Co.

Korro Bio Inc : Piper Sandler Cuts to Neutral From Overweight; Cuts Target Price to $11 From $180

THOMSON REUTERS

Korro Bio Inc : Raymond James Cuts to Market Perform From Strong Buy

THOMSON REUTERS

Korro Bio's Pivot to GaINac Pragmatic After 'Disappointing' KRRO-110 Data, RBC Says

MT Newswires Live

RBC Downgrades Korro Bio to Sector Perform From Outperform, Slashes Price Target to $8 From $85, Keeps Speculative Risk

MT Newswires Live

Korro Bio Shares Drop 78.5% Premarket After Experimental Drug Krro-110 Fails in Trial, Pauses Novo Nordisk Deal

THOMSON REUTERS

Korro Bio Inc : RBC Cuts to Sector Perform From Outperorm; Cuts Target Price to $8 From $85

THOMSON REUTERS

Korro Bio Inc : H.c. Wainwright Cuts to Neutral Rating

THOMSON REUTERS

U.S. RESEARCH ROUNDUP-Abbvie, BristolMyers Squibb, Diversified Healthcare

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/KRRO/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"KRRO","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KRRO\",,,,,undefined,":{"symbol":"KRRO","market":"US","secType":"STK","nameCN":"Korro Bio, Inc.","latestPrice":11.76,"timestamp":1773259200000,"preClose":11.48,"halted":0,"volume":181740,"delay":0,"changeRate":0.024390243902438966,"floatShares":5744014,"shares":9417295,"eps":-9.422738,"marketStatus":"Pre-Mkt","change":0.28,"latestTime":"03-12 05:22:32 EDT","open":11.43,"high":11.96,"low":11.35,"amount":2133770.44764,"amplitude":0.053136,"askPrice":12.88,"askSize":44,"bidPrice":5.5,"bidSize":46,"shortable":3,"etf":0,"ttmEps":-9.422738,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1773322200000},"marketStatusCode":1,"adr":0,"listingDate":1570075200000,"exchange":"NASDAQ","adjPreClose":11.76,"postHourTrading":{"tag":"盘后","latestPrice":11.76,"preClose":11.76,"latestTime":"17:49 EDT","volume":606,"amount":7100.8529,"timestamp":1773265793889,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.6199302773729296,"impliedVol":1.7489,"impliedVolPercentile":0.8763},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KRRO\",,,,,undefined,":{"symbol":"KRRO","floatShares":5744014,"roa":"-29.16%","roe":"-63.46%","lyrEps":-9.369477,"volumeRatio":0.6199302773729296,"shares":9417295,"dividePrice":0,"high":11.96,"amplitude":0.053136,"preClose":11.48,"low":11.35,"week52Low":5.2044,"pbRate":"1.12","psRate":"15.02","week52High":55.89,"institutionHeld":0,"latestPrice":11.76,"committee":0.022222,"eps":-9.422738,"divideRate":0,"volume":181740,"delay":0,"ttmEps":-9.422738,"open":11.43,"prevYearClose":8.01,"prevWeekClose":11.18,"prevMonthClose":12.13,"prevQuarterClose":8.01,"fiveDayClose":11.15,"twentyDayClose":12.14,"sixtyDayClose":7.9},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/KRRO\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-12","symbol":"KRRO","fiscalQuarterEnding":"2025/09","expectedEps":-2.61,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1762923600000,"reportTimeType":"post","actualEps":-1.92},{"market":"US","date":"2025-08-12","symbol":"KRRO","fiscalQuarterEnding":"2025/06","expectedEps":-2.54,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1754971200000,"reportTimeType":"pre","actualEps":-2.74},{"market":"US","date":"2025-05-07","symbol":"KRRO","fiscalQuarterEnding":"2025/03","expectedEps":-2.6,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1746590400000,"reportTimeType":"post","actualEps":-2.49},{"market":"US","date":"2025-03-18","symbol":"KRRO","fiscalQuarterEnding":"2024/12","expectedEps":-2.33,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1742270400000,"reportTimeType":"pre","actualEps":-2.26},{"market":"US","date":"2024-11-12","symbol":"KRRO","fiscalQuarterEnding":"2024/09","expectedEps":-2.55,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"post","actualEps":-2.26}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"KRRO\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"KRRO\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2,"buy":0.5,"hold":0.3,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5,"analysts":10,"updateTime":1771473600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/KRRO\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"KRRO","date":"2026-03-10","current":-1.248045,"percent":0.830961,"low":-8.894386,"twenty":-5.616105,"median":-3.979548,"eighty":-1.474143,"high":-0.562373,"avg":-3.781716,"sd":2.065001,"marketCap":122023908},"quantilePoints":[{"date":"2023-11-10","current":-4.581336,"twenty":-4.600294,"median":-4.593185,"eighty":-4.586076,"marketCap":328848276},{"date":"2023-11-17","current":-4.545683,"twenty":-4.815324,"median":-4.662668,"eighty":-4.586076,"marketCap":326289146},{"date":"2023-11-24","current":-4.263806,"twenty":-4.730727,"median":-4.581336,"eighty":-4.305029,"marketCap":306056020},{"date":"2023-12-01","current":-4.669353,"twenty":-4.669353,"median":-4.511145,"eighty":-4.263806,"marketCap":335166130},{"date":"2023-12-08","current":-5.29327,"twenty":-5.459276,"median":-4.605034,"eighty":-4.305029,"marketCap":379950915},{"date":"2023-12-15","current":-5.927214,"twenty":-5.596315,"median":-4.70004,"eighty":-4.344024,"marketCap":425455455},{"date":"2023-12-22","current":-5.775692,"twenty":-5.775692,"median":-5.29327,"eighty":-4.447639,"marketCap":414579150},{"date":"2023-12-29","current":-5.477103,"twenty":-5.763659,"median":-5.468189,"eighty":-4.46502,"marketCap":393146432},{"date":"2024-01-05","current":-5.57069,"twenty":-5.744941,"median":-5.477103,"eighty":-4.490422,"marketCap":399864150},{"date":"2024-01-12","current":-4.878811,"twenty":-5.700822,"median":-5.48323,"eighty":-4.552814,"marketCap":350201022},{"date":"2024-01-19","current":-4.570194,"twenty":-5.695474,"median":-5.467075,"eighty":-4.570194,"marketCap":328048548},{"date":"2024-01-26","current":-5.793518,"twenty":-5.702159,"median":-5.459276,"eighty":-4.579107,"marketCap":415858716},{"date":"2024-02-02","current":-5.903818,"twenty":-5.702159,"median":-5.475988,"eighty":-4.581336,"marketCap":423776026},{"date":"2024-02-09","current":-6.542219,"twenty":-5.793518,"median":-5.496043,"eighty":-4.605034,"marketCap":469600457},{"date":"2024-02-16","current":-6.005204,"twenty":-5.995177,"median":-5.561777,"eighty":-4.662668,"marketCap":431053553},{"date":"2024-02-23","current":-5.637539,"twenty":-6.009661,"median":-5.57459,"eighty":-4.668016,"marketCap":404662519},{"date":"2024-03-01","current":-5.381287,"twenty":-5.997182,"median":-5.57069,"eighty":-4.718452,"marketCap":386268768},{"date":"2024-03-08","current":-5.46819,"twenty":-5.954177,"median":-5.56679,"eighty":-4.734215,"marketCap":392506649},{"date":"2024-03-15","current":-6.597926,"twenty":-6.029715,"median":-5.57069,"eighty":-4.778761,"marketCap":473599099},{"date":"2024-03-22","current":-7.241897,"twenty":-6.148928,"median":-5.582946,"eighty":-4.827114,"marketCap":519823395},{"date":"2024-03-28","current":-8.749112,"twenty":-6.225581,"median":-5.594644,"eighty":-4.85118,"marketCap":710182879},{"date":"2024-04-05","current":-7.056213,"twenty":-6.445289,"median":-5.625283,"eighty":-4.87168,"marketCap":572766944},{"date":"2024-04-12","current":-7.760846,"twenty":-6.653602,"median":-5.643524,"eighty":-4.982426,"marketCap":629963419},{"date":"2024-04-19","current":-6.599635,"twenty":-6.850878,"median":-5.695474,"eighty":-5.142416,"marketCap":535705553},{"date":"2024-04-26","current":-6.686174,"twenty":-6.869775,"median":-5.765664,"eighty":-5.203025,"marketCap":542730135},{"date":"2024-05-03","current":-6.650761,"twenty":-6.964451,"median":-5.793518,"eighty":-5.219737,"marketCap":539855604},{"date":"2024-05-10","current":-6.269217,"twenty":-6.920952,"median":-5.915516,"eighty":-5.240905,"marketCap":508884843},{"date":"2024-05-17","current":-5.859151,"twenty":-6.869775,"median":-5.859151,"eighty":-5.274998,"marketCap":475317730},{"date":"2024-05-24","current":-5.495668,"twenty":-6.850878,"median":-5.84806,"eighty":-5.34608,"marketCap":445830598},{"date":"2024-05-31","current":-5.743893,"twenty":-6.8128,"median":-5.816278,"eighty":-5.412483,"marketCap":465967596},{"date":"2024-06-07","current":-5.114065,"twenty":-6.734223,"median":-5.793518,"eighty":-5.389162,"marketCap":414873438},{"date":"2024-06-14","current":-4.858019,"twenty":-6.694902,"median":-5.775692,"eighty":-5.295379,"marketCap":394101947},{"date":"2024-06-21","current":-4.102454,"twenty":-6.686174,"median":-5.755637,"eighty":-5.203025,"marketCap":332807503},{"date":"2024-06-28","current":-3.825833,"twenty":-6.685159,"median":-5.743893,"eighty":-5.149649,"marketCap":310366874},{"date":"2024-07-05","current":-4.380219,"twenty":-6.677519,"median":-5.73799,"eighty":-4.872237,"marketCap":355340861},{"date":"2024-07-12","current":-5.240945,"twenty":-6.652589,"median":-5.708166,"eighty":-4.858612,"marketCap":425166453},{"date":"2024-07-15","current":-5.618156,"twenty":-6.652132,"median":-5.702159,"eighty":-4.859205,"marketCap":455767311},{"date":"2024-08-02","current":-4.971182,"twenty":-6.651675,"median":-5.698816,"eighty":-4.859798,"marketCap":403282204},{"date":"2024-08-09","current":-4.113885,"twenty":-6.640451,"median":-5.660935,"eighty":-4.773204,"marketCap":333734802},{"date":"2024-08-16","current":-4.916432,"twenty":-6.613212,"median":-5.643524,"eighty":-4.733343,"marketCap":419376556},{"date":"2024-08-23","current":-4.817231,"twenty":-6.59861,"median":-5.625283,"eighty":-4.733343,"marketCap":410914634},{"date":"2024-08-30","current":-5.446229,"twenty":-6.597297,"median":-5.604672,"eighty":-4.737935,"marketCap":464568797},{"date":"2024-09-06","current":-4.658074,"twenty":-6.575014,"median":-5.590187,"eighty":-4.732471,"marketCap":397338364},{"date":"2024-09-13","current":-4.408437,"twenty":-6.520293,"median":-5.578489,"eighty":-4.665342,"marketCap":376044078},{"date":"2024-09-20","current":-4.196954,"twenty":-6.477243,"median":-5.57069,"eighty":-4.6075,"marketCap":358004377},{"date":"2024-09-27","current":-3.78816,"twenty":-6.457997,"median":-5.564005,"eighty":-4.555487,"marketCap":323133821},{"date":"2024-10-04","current":-3.412069,"twenty":-6.444854,"median":-5.520554,"eighty":-4.463176,"marketCap":291052909},{"date":"2024-10-11","current":-3.984381,"twenty":-6.396267,"median":-5.495668,"eighty":-4.391506,"marketCap":339871688},{"date":"2024-10-18","current":-8.722034,"twenty":-6.444854,"median":-5.494185,"eighty":-4.372675,"marketCap":743998188},{"date":"2024-10-25","current":-7.426973,"twenty":-6.575014,"median":-5.518326,"eighty":-4.380219,"marketCap":633528265},{"date":"2024-10-31","current":-6.633368,"twenty":-6.626621,"median":-5.552864,"eighty":-4.385863,"marketCap":565832892},{"date":"2024-11-08","current":-7.532715,"twenty":-6.647324,"median":-5.570133,"eighty":-4.416277,"marketCap":642548116},{"date":"2024-11-15","current":-5.302508,"twenty":-6.677519,"median":-5.57069,"eighty":-4.447647,"marketCap":465602621},{"date":"2024-11-22","current":-5.400663,"twenty":-6.652589,"median":-5.56679,"eighty":-4.448989,"marketCap":474221422},{"date":"2024-11-29","current":-5.554297,"twenty":-6.650761,"median":-5.56679,"eighty":-4.454222,"marketCap":487711719},{"date":"2024-12-06","current":-4.173725,"twenty":-6.633578,"median":-5.554297,"eighty":-4.447681,"marketCap":366486409},{"date":"2024-12-13","current":-4.690106,"twenty":-6.633368,"median":-5.55038,"eighty":-4.454222,"marketCap":411828797},{"date":"2024-12-20","current":-4.600486,"twenty":-6.599635,"median":-5.518326,"eighty":-4.476607,"marketCap":403959457},{"date":"2024-12-27","current":-4.39564,"twenty":-6.598268,"median":-5.495668,"eighty":-4.47213,"marketCap":385972394},{"date":"2025-01-03","current":-4.376436,"twenty":-6.597297,"median":-5.489358,"eighty":-4.431958,"marketCap":384286107},{"date":"2025-01-10","current":-4.013689,"twenty":-6.580078,"median":-5.474874,"eighty":-4.400759,"marketCap":352434016},{"date":"2025-01-17","current":-3.945407,"twenty":-6.549815,"median":-5.463733,"eighty":-4.371161,"marketCap":346438328},{"date":"2025-01-24","current":-4.049964,"twenty":-6.531256,"median":-5.447319,"eighty":-4.329948,"marketCap":355619225},{"date":"2025-01-31","current":-3.646675,"twenty":-6.482324,"median":-5.400974,"eighty":-4.264567,"marketCap":320207195},{"date":"2025-02-07","current":-3.864323,"twenty":-6.459999,"median":-5.376271,"eighty":-4.20066,"marketCap":339318449},{"date":"2025-02-14","current":-3.102554,"twenty":-6.448423,"median":-5.308909,"eighty":-4.176092,"marketCap":272429058},{"date":"2025-02-21","current":-3.056677,"twenty":-6.434147,"median":-5.302508,"eighty":-4.119313,"marketCap":268400706},{"date":"2025-02-28","current":-2.638451,"twenty":-6.340126,"median":-5.244267,"eighty":-4.093707,"marketCap":231677119},{"date":"2025-03-07","current":-2.367458,"twenty":-6.339446,"median":-5.203025,"eighty":-4.06287,"marketCap":207881733},{"date":"2025-03-14","current":-2.630983,"twenty":-6.269217,"median":-5.198397,"eighty":-4.049964,"marketCap":231021340},{"date":"2025-03-21","current":-2.460092,"twenty":-6.255885,"median":-5.114065,"eighty":-3.984381,"marketCap":205616953},{"date":"2025-03-28","current":-2.06468,"twenty":-6.247779,"median":-5.067789,"eighty":-3.960398,"marketCap":172568018},{"date":"2025-04-04","current":-1.656911,"twenty":-6.240921,"median":-5.016723,"eighty":-3.945407,"marketCap":138486304},{"date":"2025-04-11","current":-1.456959,"twenty":-6.236945,"median":-4.994706,"eighty":-3.88409,"marketCap":121774058},{"date":"2025-04-17","current":-1.512002,"twenty":-6.221793,"median":-4.974969,"eighty":-3.861976,"marketCap":126374620},{"date":"2025-04-25","current":-1.959087,"twenty":-6.206418,"median":-4.916432,"eighty":-3.824403,"marketCap":163742450},{"date":"2025-05-02","current":-2.066365,"twenty":-6.177673,"median":-4.874702,"eighty":-3.775951,"marketCap":172708852},{"date":"2025-05-09","current":-1.654409,"twenty":-6.170108,"median":-4.860984,"eighty":-3.687236,"marketCap":144613576},{"date":"2025-05-16","current":-1.555575,"twenty":-6.148652,"median":-4.836663,"eighty":-3.631696,"marketCap":135974324},{"date":"2025-05-23","current":-1.591026,"twenty":-6.130879,"median":-4.78968,"eighty":-3.512031,"marketCap":139073186},{"date":"2025-05-30","current":-1.260144,"twenty":-6.108373,"median":-4.78372,"eighty":-3.223328,"marketCap":110150471},{"date":"2025-06-06","current":-1.32675,"twenty":-6.061356,"median":-4.749297,"eighty":-3.117918,"marketCap":115972576},{"date":"2025-06-13","current":-1.50186,"twenty":-6.034499,"median":-4.735087,"eighty":-2.776295,"marketCap":131279078},{"date":"2025-06-20","current":-1.338568,"twenty":-6.030043,"median":-4.699133,"eighty":-2.705652,"marketCap":117005530},{"date":"2025-06-27","current":-1.325676,"twenty":-6.018574,"median":-4.677957,"eighty":-2.666335,"marketCap":115878671},{"date":"2025-07-03","current":-1.43418,"twenty":-6.003199,"median":-4.660916,"eighty":-2.628422,"marketCap":125363068},{"date":"2025-07-11","current":-1.459963,"twenty":-5.99384,"median":-4.62319,"eighty":-2.383248,"marketCap":127616786},{"date":"2025-07-18","current":-1.485746,"twenty":-5.986149,"median":-4.615445,"eighty":-2.328623,"marketCap":129870504},{"date":"2025-07-25","current":-1.708124,"twenty":-5.970205,"median":-4.600486,"eighty":-2.093296,"marketCap":149308822},{"date":"2025-08-01","current":-1.607141,"twenty":-5.940584,"median":-4.57486,"eighty":-1.999527,"marketCap":140481760},{"date":"2025-08-08","current":-1.703827,"twenty":-5.922535,"median":-4.545683,"eighty":-1.959761,"marketCap":148933203},{"date":"2025-08-15","current":-2.043579,"twenty":-5.895837,"median":-4.518539,"eighty":-1.949427,"marketCap":186691151},{"date":"2025-08-22","current":-2.112452,"twenty":-5.862962,"median":-4.454222,"eighty":-1.956391,"marketCap":192983056},{"date":"2025-08-29","current":-2.433175,"twenty":-5.854715,"median":-4.430175,"eighty":-1.959087,"marketCap":222282674},{"date":"2025-09-05","current":-2.887018,"twenty":-5.836969,"median":-4.402038,"eighty":-1.959087,"marketCap":263743510},{"date":"2025-09-12","current":-3.535145,"twenty":-5.825985,"median":-4.380219,"eighty":-1.962457,"marketCap":322953154},{"date":"2025-09-19","current":-3.414874,"twenty":-5.825526,"median":-4.355835,"eighty":-1.96751,"marketCap":311965797},{"date":"2025-09-26","current":-3.921657,"twenty":-5.806571,"median":-4.328858,"eighty":-1.980874,"marketCap":358262949},{"date":"2025-10-03","current":-4.69982,"twenty":-5.793518,"median":-4.339167,"eighty":-1.984924,"marketCap":429352085},{"date":"2025-10-10","current":-4.804672,"twenty":-5.786833,"median":-4.376436,"eighty":-1.99391,"marketCap":438930806},{"date":"2025-10-17","current":-4.995872,"twenty":-5.775692,"median":-4.38793,"eighty":-1.995034,"marketCap":456397885},{"date":"2025-10-24","current":-3.854839,"twenty":-5.770184,"median":-4.380219,"eighty":-2.0175,"marketCap":352158862},{"date":"2025-10-31","current":-3.746904,"twenty":-5.755637,"median":-4.355835,"eighty":-2.027132,"marketCap":342298414},{"date":"2025-11-07","current":-3.348057,"twenty":-5.743893,"median":-4.33284,"eighty":-2.032103,"marketCap":305861710},{"date":"2025-11-14","current":-0.67005,"twenty":-5.739166,"median":-4.291871,"eighty":-2.032103,"marketCap":61212417},{"date":"2025-11-21","current":-0.637995,"twenty":-5.73799,"median":-4.263806,"eighty":-1.99391,"marketCap":56409597},{"date":"2025-11-28","current":-0.607107,"twenty":-5.724273,"median":-4.259855,"eighty":-1.966499,"marketCap":53678581},{"date":"2025-12-05","current":-0.725333,"twenty":-5.715508,"median":-4.21043,"eighty":-1.954144,"marketCap":64131778},{"date":"2025-12-12","current":-0.841429,"twenty":-5.70918,"median":-4.195844,"eighty":-1.830004,"marketCap":74396630},{"date":"2025-12-19","current":-0.832908,"twenty":-5.703313,"median":-4.178846,"eighty":-1.734551,"marketCap":73643246},{"date":"2025-12-26","current":-0.895749,"twenty":-5.698148,"median":-4.175072,"eighty":-1.71414,"marketCap":79199450},{"date":"2026-01-02","current":-0.853145,"twenty":-5.689788,"median":-4.172125,"eighty":-1.703182,"marketCap":75432532},{"date":"2026-01-09","current":-0.974567,"twenty":-5.676061,"median":-4.119313,"eighty":-1.677034,"marketCap":86168249},{"date":"2026-01-16","current":-0.937288,"twenty":-5.665333,"median":-4.107026,"eighty":-1.662811,"marketCap":82872196},{"date":"2026-01-23","current":-1.11942,"twenty":-5.660609,"median":-4.081971,"eighty":-1.645845,"marketCap":98975770},{"date":"2026-01-30","current":-1.417648,"twenty":-5.657347,"median":-4.065967,"eighty":-1.61564,"marketCap":125344196},{"date":"2026-02-06","current":-1.229125,"twenty":-5.647115,"median":-4.062285,"eighty":-1.591885,"marketCap":108675584},{"date":"2026-02-13","current":-1.252558,"twenty":-5.635533,"median":-4.060161,"eighty":-1.565529,"marketCap":110747389},{"date":"2026-02-20","current":-1.246167,"twenty":-5.627511,"median":-4.013689,"eighty":-1.532222,"marketCap":110182351},{"date":"2026-02-27","current":-1.288771,"twenty":-5.625283,"median":-3.995468,"eighty":-1.512002,"marketCap":113949269},{"date":"2026-03-06","current":-1.166285,"twenty":-5.618156,"median":-3.983816,"eighty":-1.485746,"marketCap":103119380},{"date":"2026-03-10","current":-1.380096,"twenty":-5.616105,"median":-3.979548,"eighty":-1.474143,"marketCap":122023908}],"updateTime":1773281662121},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"KRRO\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2606758050","title":"Korro Bio upgraded to Overweight from Neutral at Cantor Fitzgerald","url":"https://stock-news.laohu8.com/highlight/detail?id=2606758050","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606758050?lang=en_us&edition=fundamental","pubTime":"2026-01-28 05:17","pubTimestamp":1769548657,"startTime":"0","endTime":"0","summary":"Cantor Fitzgerald analyst Steve Seedhouse upgraded Korro Bio (KRRO) to Overweight from Neutral with a $21 price target The upgrade reflects confide...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/korro-bio-upgraded-to-overweight-from-neutral-at-cantor-fitzgerald-thefly-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/korro-bio-upgraded-to-overweight-from-neutral-at-cantor-fitzgerald-thefly-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["KRRO","BK4139"],"gpt_icon":0},{"id":"2606675809","title":"Korro Bio price target raised to $10 from $7 at Clear Street","url":"https://stock-news.laohu8.com/highlight/detail?id=2606675809","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606675809?lang=en_us&edition=fundamental","pubTime":"2026-01-28 05:15","pubTimestamp":1769548526,"startTime":"0","endTime":"0","summary":"Clear Street raised the firm’s price target on Korro Bio (KRRO) to $10 from $7 and keeps a Hold rating on the shares following the analyst day. The...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/korro-bio-price-target-raised-to-10-from-7-at-clear-street-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/korro-bio-price-target-raised-to-10-from-7-at-clear-street-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["KRRO","BK4139"],"gpt_icon":0},{"id":"2606342735","title":"Korro Bio Inc. Releases Overview of KRRO-121 RNA Editing Therapy for Ammonia Control","url":"https://stock-news.laohu8.com/highlight/detail?id=2606342735","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606342735?lang=en_us&edition=fundamental","pubTime":"2026-01-27 23:30","pubTimestamp":1769527843,"startTime":"0","endTime":"0","summary":"Korro Bio Inc. published a document outlining the development of KRRO-121, a potential treatment for ammonia control in conditions such as urea cycle disorders and hepatic encephalopathy. The document includes scientific overviews, preclinical data, product profile information, and perspectives from clinicians and patients. The full document can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Korro Bio Inc. published the original content used to generate this news brief on January 27, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260127:nNDL5wDdLx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KRRO","BK4139"],"gpt_icon":0},{"id":"2606733989","title":"Korro Bio Showcases KRRO-121 RNA Editing Program Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=2606733989","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606733989?lang=en_us&edition=fundamental","pubTime":"2026-01-27 22:49","pubTimestamp":1769525355,"startTime":"0","endTime":"0","summary":"Korro Bio ( ($KRRO) ) has provided an announcement. On January 27, 2026, Korro Bio, Inc. held a virtual Analyst Day where management presented KRRO...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/korro-bio-showcases-krro-121-rna-editing-program-progress?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/korro-bio-showcases-krro-121-rna-editing-program-progress?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RNA","BK4588","LU2065732104.USD","BK4097","KRRO","BK4139","BK4585","IE0009354923.USD","PRGS","BK4505"],"gpt_icon":0},{"id":"2604113257","title":"Korro Bio Hosts Virtual Analyst Day to Spotlight KRRO-121 for Hyperammonemia","url":"https://stock-news.laohu8.com/highlight/detail?id=2604113257","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604113257?lang=en_us&edition=fundamental","pubTime":"2026-01-20 21:02","pubTimestamp":1768914133,"startTime":"0","endTime":"0","summary":"Korro Bio Inc. will host a virtual Analyst Day on January 27, 2026, from 8 a.m. to 10 a.m. ET. The event will feature presentations from the company's management team, a leading clinical hepatologist, and a caregiver to discuss KRRO-121 for the potential treatment of hyperammonemia, as well as provide insights into ammonia-driven diseases and the challenges faced by those living with urea cycle disorders.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Korro Bio Inc. published the original content used to generate this news brief via GlobeNewswire  on January 20, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260120:nNDLb0HCbY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B64PRP62.GBP","IE00BKPKM429.USD","LU2095319765.USD","LU2210149790.SGD","LU2210150020.SGD","KRRO","BK4588","IE00BGHQF748.EUR","BK4112","LU0314104364.USD","SG9999014039.USD","SG9999014005.SGD","NDAQ","IE00B3QW5Z07.USD","SG9999014013.SGD","BK4139","SG9999014021.USD","BK4585"],"gpt_icon":0},{"id":"2603936397","title":"Korro Bio Updates Pipeline, Terminates KRRO-110 REWRITE Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2603936397","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603936397?lang=en_us&edition=fundamental","pubTime":"2026-01-16 05:33","pubTimestamp":1768512786,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Korro Bio ( ($KRRO) ). On January 15, 2026, Korro Bio, Inc. updated its corporate presentation for investors an...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/korro-bio-updates-pipeline-terminates-krro-110-rewrite-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/korro-bio-updates-pipeline-terminates-krro-110-rewrite-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["KRRO","BK4139"],"gpt_icon":0},{"id":"2603384959","title":"Korro Bio Unveils Pipeline Advancements in RNA Editing for Genetic Medicines","url":"https://stock-news.laohu8.com/highlight/detail?id=2603384959","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603384959?lang=en_us&edition=fundamental","pubTime":"2026-01-16 03:27","pubTimestamp":1768505253,"startTime":"0","endTime":"0","summary":"Korro Bio Inc. has provided an update on its pipeline of RNA editing-based therapeutic candidates targeting rare and prevalent diseases. The company highlighted the progress of its lead asset, KRRO-121, aimed at treating hyperammonemia, with an update expected on January 27, 2026. Additional programs include efforts to repair pathogenic variants in Alpha-1 Antitrypsin Deficiency  and to develop allosteric activators for longevity, all utilizing GalNAc-based delivery for liver targeting. The presentation also outlined anticipated milestones for 2026 and described the company's emphasis on leveraging ADAR biology, machine learning, and advanced chemistry to drive drug discovery and development. Korro Bio reported a cash position of $102.5 million as of September 30, 2025, projecting a runway into the second half of 2027. You can access the full presentation through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. Whi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260115:nNDL1kn4Xv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","KRRO"],"gpt_icon":0},{"id":"2592918197","title":"Korro Bio Boosts Executive Pay and Severance in New Agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2592918197","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592918197?lang=en_us&edition=fundamental","pubTime":"2025-12-19 05:06","pubTimestamp":1766091973,"startTime":"0","endTime":"0","summary":"Korro Bio Inc. has entered into an amended and restated employment agreement with Jeffrey Cerio, effective December 15, 2025. The new agreement increases Dr. Cerio's annual base salary to $425,000 and enhances severance terms, providing nine months of salary in the event of termination without cause or resignation for good reason, and 12 months of salary in similar circumstances within the change in control period. Dr. Cerio has also been awarded a $100,000 cash bonus, payable in two installments—half on December 31, 2025, and half on or about June 30, 2026—contingent on continued service. Additionally, he has been granted 41,902 restricted stock units, vesting in two equal tranches on June 15, 2026, and December 15, 2026, subject to continued service.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251218:nNDL5LdXHy:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","KRRO"],"gpt_icon":0},{"id":"2583524516","title":"Korro Bio Early Trial Results Fall Short; Stock Hits New Low","url":"https://stock-news.laohu8.com/highlight/detail?id=2583524516","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583524516?lang=en_us&edition=fundamental","pubTime":"2025-11-14 03:26","pubTimestamp":1763061960,"startTime":"0","endTime":"0","summary":"Korro Bio shares drop after KRRO-110 trial in AATD misses protein goals; company cuts 34% of staff and shifts focus to liver-targeted programs.","market":"nz","thumbnail":"https://cdn.benzinga.com/files/images/story/2025/11/13/Medical-Development-Laboratory-Caucasian.jpeg?optimize=medium&dpr=2&auto=webp&width=260","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2025/11/13/Medical-Development-Laboratory-Caucasian.jpeg?optimize=medium&dpr=2&auto=webp&width=260"],"rights":{"source":"benzinga_hot_news","url":"https://www.benzinga.com/analyst-stock-ratings/analyst-color/25/11/48846497/korro-bio-early-trial-results-fall-short-stock-hits-new-low","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/analyst-stock-ratings/analyst-color/25/11/48846497/korro-bio-early-trial-results-fall-short-stock-hits-new-low","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_hot_news","symbols":["BK4081","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","HE","KRRO","LU1093756325.SGD","BK4599","LU1093756168.USD","BK4585","BK4588","LU0154236417.USD","BK4007","BK4139","BK4532"],"gpt_icon":1},{"id":"2583059311","title":"Korro failure strengthens Wave Life Sciences position, says Jefferies","url":"https://stock-news.laohu8.com/highlight/detail?id=2583059311","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583059311?lang=en_us&edition=fundamental","pubTime":"2025-11-13 21:35","pubTimestamp":1763040926,"startTime":"0","endTime":"0","summary":"Korro Bio’s (KRRO) lead asset KRRO-110 failing to produce protective levels of corrected protein in a Phase 1/2 AATD trial, leading to its disconti...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/korro-failure-strengthens-wave-life-sciences-position-says-jefferies-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/korro-failure-strengthens-wave-life-sciences-position-says-jefferies-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["KRRO","BK4139"],"gpt_icon":0},{"id":"2583560741","title":"Korro Bio downgraded to Neutral from Overweight at Piper Sandler","url":"https://stock-news.laohu8.com/highlight/detail?id=2583560741","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583560741?lang=en_us&edition=fundamental","pubTime":"2025-11-13 20:51","pubTimestamp":1763038262,"startTime":"0","endTime":"0","summary":"Piper Sandler analyst Yasmeen Rahimi downgraded Korro Bio (KRRO) to Neutral from Overweight with a price target of $11, down from $180. Published f...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/korro-bio-downgraded-to-neutral-from-overweight-at-piper-sandler-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/korro-bio-downgraded-to-neutral-from-overweight-at-piper-sandler-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","KRRO"],"gpt_icon":0},{"id":"2583256050","title":"Korro Bio Cut to Neutral From Buy by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2583256050","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583256050?lang=en_us&edition=fundamental","pubTime":"2025-11-13 20:49","pubTimestamp":1763038140,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/KRRO/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  November 13, 2025 07:49 ET (12:49 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KRRO","BK4139"],"gpt_icon":0},{"id":"2583677015","title":"Korro Bio Inc : Piper Sandler Cuts to Neutral From Overweight; Cuts Target Price to $11 From $180","url":"https://stock-news.laohu8.com/highlight/detail?id=2583677015","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583677015?lang=en_us&edition=fundamental","pubTime":"2025-11-13 20:40","pubTimestamp":1763037632,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251113:nFWN3WP1PT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["KRRO","BK4139"],"gpt_icon":0},{"id":"2583956764","title":"Korro Bio Inc : Raymond James Cuts to Market Perform From Strong Buy","url":"https://stock-news.laohu8.com/highlight/detail?id=2583956764","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583956764?lang=en_us&edition=fundamental","pubTime":"2025-11-13 20:30","pubTimestamp":1763037057,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251113:nFWN3WP1PK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","KRRO"],"gpt_icon":0},{"id":"2583567596","title":"Korro Bio's Pivot to GaINac Pragmatic After 'Disappointing' KRRO-110 Data, RBC Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2583567596","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583567596?lang=en_us&edition=fundamental","pubTime":"2025-11-13 20:29","pubTimestamp":1763036954,"startTime":"0","endTime":"0","summary":"Korro Bio's (KRRO) move to prioritize GaINac-conjugated programs that target the liver is the pragmatic approach after the \"disappointing\" data on its KRRO-110 product candidate, RBC Capital Markets s","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["KRRO","BK4139"],"gpt_icon":0},{"id":"2583648955","title":"RBC Downgrades Korro Bio to Sector Perform From Outperform, Slashes Price Target to $8 From $85, Keeps Speculative Risk","url":"https://stock-news.laohu8.com/highlight/detail?id=2583648955","media":"MT Newswires Live","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583648955?lang=en_us&edition=fundamental","pubTime":"2025-11-13 19:47","pubTimestamp":1763034430,"startTime":"0","endTime":"0","summary":"Korro Bio (KRRO) has an average rating of overweight and mean price target of $62.14, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major ba","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","KRRO"],"gpt_icon":0},{"id":"2583561975","title":"Korro Bio Shares Drop 78.5% Premarket After Experimental Drug Krro-110 Fails in Trial, Pauses Novo Nordisk Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2583561975","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583561975?lang=en_us&edition=fundamental","pubTime":"2025-11-13 19:36","pubTimestamp":1763033805,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251113:nL4N3WP0T1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["KRRO","BK4139"],"gpt_icon":0},{"id":"2583561633","title":"Korro Bio Inc : RBC Cuts to Sector Perform From Outperorm; Cuts Target Price to $8 From $85","url":"https://stock-news.laohu8.com/highlight/detail?id=2583561633","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583561633?lang=en_us&edition=fundamental","pubTime":"2025-11-13 19:31","pubTimestamp":1763033470,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251113:nFWN3WP0TI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["KRRO","BK4139"],"gpt_icon":0},{"id":"2583618095","title":"Korro Bio Inc : H.c. Wainwright Cuts to Neutral Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2583618095","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583618095?lang=en_us&edition=fundamental","pubTime":"2025-11-13 19:27","pubTimestamp":1763033227,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251113:nFWN3WP0KX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["KRRO","BK4139"],"gpt_icon":0},{"id":"2583855979","title":"U.S. RESEARCH ROUNDUP-Abbvie, BristolMyers Squibb, Diversified Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2583855979","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583855979?lang=en_us&edition=fundamental","pubTime":"2025-11-13 15:46","pubTimestamp":1763019995,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-Abbvie, BristolMyers Squibb, Diversified Healthcare Nov 13 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.listed companies, in","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251113:nL4N3WP0H3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GFS","NXT","LU2417539215.USD","ALB","MRK","LU0868494617.USD","CSCO","CELC","VAC","LU1046421795.USD","JNJ","PCH","GLXY","HTFL","LCID","GILD","AMGN","DHC","CRMD","BCSF","BMY","LEGN","PRVA","LU1221951046.USD","ABBV","CCOI","KMI","KRRO","ANAB","AKAM","CVX","KBDC","BK4020","FTCI","BK4534","LU1974910355.USD","ORKA","LU0823416689.USD","LWAY","BRBR","LU1880398471.USD","HHH","AMN","LU1221951129.SGD","LU2361045086.USD","LPRO"],"gpt_icon":1}],"pageSize":20,"totalPage":4,"pageCount":2,"totalSize":62,"code":"91000000","status":"200"}]}}